Use of antidepressant medication and risk of type 2 diabetes: results from three cohorts of US adults.
about
Cardiovascular riskDepression treatment and short-term healthcare expenditures among elderly Medicare beneficiaries with chronic physical conditions.Advancements and challenges in generating accurate animal models of gestational diabetes mellitus.Impact of Muscarinic M3 Receptor Antagonism on the Risk of Type 2 Diabetes in Antidepressant-Treated Patients: A Case-Controlled Study.Depressive symptoms, antidepressant use, and the incidence of diabetes in the Black Women's Health Study.State of the science: depression and type 2 diabetes.Antidepressant use and diabetes mellitus risk: a meta-analysis.Diet, lifestyle, and genetic risk factors for type 2 diabetes: a review from the Nurses' Health Study, Nurses' Health Study 2, and Health Professionals' Follow-up StudyAntidepressant medication as a risk factor for type 2 diabetes and impaired glucose regulation: systematic review.Antidepressant drug use and future diabetes risk.Association of severe hypoglycemia with depressive symptoms in patients with type 2 diabetes: the Fukuoka Diabetes RegistryAssociation between major depression and type 2 diabetes in midlife: findings from the Screening Across the Lifespan Twin StudyMarginal structural models for the estimation of the risk of Diabetes Mellitus in the presence of elevated depressive symptoms and antidepressant medication use in the Women's Health Initiative observational and clinical trial cohorts.Depressive symptoms, psychiatric medication use, and risk of type 2 diabetes: results from the Health and Retirement StudyGender and race disparities in weight gain among offenders prescribed antidepressant and antipsychotic medicationsCommentary: Antidepressants and diabetes risk: why are there discrepant findings from cohort studies based on patient records and those based on serial phenotyping?Whole-organism screening for gluconeogenesis identifies activators of fasting metabolism.Antidepressant use, depression, and new-onset diabetes among elderly Medicare beneficiaries.The association between antidepressant use and glycemic control in the Southern Community Cohort Study (SCCS)Effect of serotonin modulating pharmacotherapies on body mass index and dysglycaemia among children and adolescents: a systematic review and network meta-analysis protocol.Antidepressant use and new-onset diabetes: a systematic review and meta-analysis.Is ignorance bliss? Depression, antidepressants, and the diagnosis of prediabetes and type 2 diabetes.Weight and metabolic effects of dietary weight loss and exercise interventions in postmenopausal antidepressant medication users and non-users: a randomized controlled trial.Evidence-based guidance for the management of postherpetic neuralgia in primary care.Diabetes among refugee populations: what newly arriving refugees can learn from resettled Cambodians.Therapeutic concentrations of antidepressants inhibit pancreatic beta-cell function via mitochondrial complex inhibition.Depressive symptoms and glycated hemoglobin A1c: a reciprocal relationship in a prospective cohort study.Antidepressant medication use and trajectories of fasting plasma glucose, glycated haemoglobin, β-cell function and insulin sensitivity: a 9-year longitudinal study of the D.E.S.I.R. cohort.Depression and risk of type 2 diabetes: the potential role of metabolic factors.The risk of new-onset diabetes in antidepressant users - A systematic review and meta-analysisDepression, antidepressant use and breast cancer risk in pre- and postmenopausal women: a prospective cohort study.Diabetes mellitus associated with clomipramine treatment: a retrospective analysis.Antidepressant use and glycemic control.Association between major depressive episode and risk of type 2 diabetes: A large prospective cohort study in Chinese adults.The Impact of Antidepressant Therapy on Glycemic Control in Canadian Primary Care Patients With Diabetes Mellitus.Trajectory of Disability in Older Adults With Newly Diagnosed Diabetes: Role of Elevated Depressive Symptoms
P2860
Q26825634-8A7DFE51-F7A4-4666-8CFF-DCC6961D002EQ33587777-D077E0D8-956E-448F-8677-573E378DD4B4Q33816871-A1B64829-72F1-4BC5-8DAD-6768222C628DQ33845592-73979FE0-3D31-41A8-A438-46C5A860A3E2Q33960278-52FF2ED6-DD21-489B-ABF9-6B58DDADA888Q34098494-0F29CEC0-144B-480E-AB8F-730E33519647Q34886547-3F8AE274-FE88-4062-A778-1DF0ECA5EC2AQ34972703-F3F12DCA-C6DB-4953-A464-AC44D1CE59CFQ34996871-C19B1B96-A8D8-4A72-8FDD-64B516C1153FQ35587402-E2947886-3CFA-4FB8-94E6-16547983465EQ35640072-AFA826C9-6DC9-4EDD-AA99-29FA3BDFD3B4Q35695980-393A2B37-9E9C-4006-BE10-05EB7FA436E0Q35803562-BC8C5540-BA85-44DC-BE3B-03F59583BBB1Q36021649-A474CA5D-8214-483B-A07E-BAC650B4E00EQ36060797-60E1A342-2812-44CB-B930-0D81A167EE66Q36401071-0DFCF258-C904-4448-9DCE-3E64C358F192Q36553321-118F4FFD-101F-4CE8-BD74-15C5E8E4F700Q36674976-88BAB6C6-D9FE-4206-A82B-31AC9336DE85Q36676263-BA032285-2A64-4C37-8A9A-F2A6D363B74BQ36707440-3A2BFF88-8CF3-4983-A4D6-BB3266F0C56EQ36956027-5C75E16F-4CD9-4009-A520-D866D9A5CF7AQ37049657-D58D07C6-D161-416A-A4D7-0B6F0F05E793Q37238741-70BF739C-87B4-47E4-A8A0-C4271228C425Q38128177-54FFC8A3-B898-4A48-AF27-EE627B5B72C0Q38542889-7540D2DC-2216-4F78-BB4F-61605D3D65B3Q38704329-BDD34245-A166-49FF-93D1-20EE86B48F4AQ40260372-2257C70A-D4C3-414E-B7BB-B0C2C8D794B1Q40657746-9AD3697B-428A-439C-96D4-778D40276361Q40894639-F8F3DCB5-023A-4C6B-8F49-1BD33F344583Q41185364-E2307C11-EF0B-4B8D-96FF-42AC7D81725AQ47672990-4F72E826-9F36-4CB9-965A-E3BE4D9F1CEAQ48453928-53F0305D-79BC-42C0-BA69-821CDF49E092Q50726991-BB46C45B-23F9-44AF-BA88-39F55DE7B945Q53274127-EDE907BB-F0AE-4B41-839D-D344A7730C12Q55410230-C5634F7A-1AD8-4F32-91D7-0F4904462AD2Q57136890-64589758-A3E2-49A8-B8F7-AFA5FDF3ADAC
P2860
Use of antidepressant medication and risk of type 2 diabetes: results from three cohorts of US adults.
description
2011 nî lūn-bûn
@nan
2011 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Use of antidepressant medicati ...... om three cohorts of US adults.
@ast
Use of antidepressant medicati ...... om three cohorts of US adults.
@en
Use of antidepressant medicati ...... om three cohorts of US adults.
@nl
type
label
Use of antidepressant medicati ...... om three cohorts of US adults.
@ast
Use of antidepressant medicati ...... om three cohorts of US adults.
@en
Use of antidepressant medicati ...... om three cohorts of US adults.
@nl
prefLabel
Use of antidepressant medicati ...... om three cohorts of US adults.
@ast
Use of antidepressant medicati ...... om three cohorts of US adults.
@en
Use of antidepressant medicati ...... om three cohorts of US adults.
@nl
P2093
P2860
P1433
P1476
Use of antidepressant medicati ...... om three cohorts of US adults.
@en
P2093
J E Manson
K M Rexrode
O I Okereke
W C Willett
P2860
P2888
P356
10.1007/S00125-011-2268-4
P50
P577
2011-08-03T00:00:00Z
P5875
P6179
1004797757